CLCN4 ‐Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64192 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Alexandra Garrett und 4 weiteren Autor:innen. Beteiligte Einrichtung: Speech & Language, Murdoch Children's Institute, Melbourne, Australia. Hauptthemen laut MEDLINE: Chloride Channels, Neurodevelopmental Disorders, Speech. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
Speech and language difficulties are a core feature of the CLCN4 ‐related neurodevelopmental condition, but these have not been well described. Here we systematically phenotype speech and language in 13 participants (10 female, aged 1 year 10 months–41 years 10 months) with pathogenic CLCN4 variants (12 missense de novo, 1 premature stop codon maternal inheritance). Speech, language, and augmentative and alternative communication (AAC) methods were examined. Expressive and receptive language conditions were highly penetrant (12/13, 92%). Eight participants were minimally verbal but used a range of low (e.g., gesture) and high‐tech (e.g., device) methods to communicate. Verbal participants had both apraxia and dysarthria, characterized by inconsistent productions, sound distortions, resonance changes, and persistent voice quality and prosodic errors. Participants were all intentional communicators, being motivated to get their message across. A discrepancy was present, however, between the ability to express basic needs versus demonstrate social skills or social exchanges. Data highlight the potential for the implementation of tailored AAC to enhance functional social participation and extend language abilities. Communication difficulties are pervasive in CLCN4‐ related neurodevelopmental condition. Data emphasize the importance of individualized and timely speech therapy, and particularly the introduction of AAC to optimize language growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Speech & Language, Murdoch Children's Institute, Melbourne, Australia.
- Max Planck Institute for Molecular Genetics, Group Development and Disease, Berlin, Germany.
- Cure CLCN4, London, UK.
- Centre for Clinical Genetics, Sydney Children's Hospital Network, Randwick, Australia.
- Discipline of Paediatrics and Child Health, Faculty of Medicine and Health, University of New South Wales, Randwick, Australia.
- Department of Paediatrics, University of Melbourne, Parkville, Australia.
ORCID-Profile: Alexandra Garrett, Elizabeth E Palmer, Angela T Morgan
Förderung
- National Health and Medical Research Council (NHMRC)
Zitieren
APA
Garrett, A., Kalscheuer, V. M., Figueroa, R. R., Palmer, E. E., & Morgan, A. T. (2025). CLCN4 ‐Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64192
Vancouver
Garrett A, Kalscheuer VM, Figueroa RR, Palmer EE, Morgan AT. CLCN4 ‐Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64192
BibTeX
@article{Garrett2025,
author = {Garrett, Alexandra and Kalscheuer, Vera M and Figueroa, Rebeca Ridings and Palmer, Elizabeth E and Morgan, Angela T},
title = {CLCN4 ‐Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64192}
}
EUVIMED